Last updated 32 days ago
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
60 patients around the world
Available in Argentina
Janssen Research & Development, LLC
5Research sites
60Patients around the world
This study is for people with
Arthritis
Psoriasic arthritis
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Sites
Lavalle 506, San Miguel de Tucumán
StudyPSUMMIT-Jr
SponsorJanssen Research & Development, LLC
Study typeInterventional
Conditions
Psoriasic arthritis
Requirements
To 17 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05083182
